Burn Care Expansion PolyNovo's collaboration with Spectral AI to introduce the DeepView System for burn indication in Australia signals a targeted entry into burn wound care. This creates opportunities to cross sell PolyNovo wound care devices and related diagnostics to Australian burn centers, hospitals and clinics, leveraging the DeepView integration for differentiated outcomes.

Indication Growth PolyNovo is investing for growth through new products, indications and markets, presenting sales opportunities to upsell to current customers and cross sell into additional wound care segments beyond existing offerings such as acute complex wounds.

R&D Funding The Victorian Government grant support for R&D signals potential for joint development programs and funded pilots with hospitals and clinics. This creates openings for co funded trials, procurement partnerships and expanded product ranges in the Australian market.

Manufacturing Scale A ramped manufacturing facility and leadership hires indicate capacity to scale orders domestically and internationally. This makes PolyNovo a viable supplier for large multi site wound care programs and hospital networks seeking reliable, scalable wound management solutions.

Global Footprint A track record treating over 106,000 patients across 46 countries demonstrates established international adoption and a baseline of case studies. Use these references to approach new distributors and health systems, highlighting proven outcomes to accelerate market entry and cross border expansion.